Olympus Expands iTind Center of Excellence Network with New Urologists
Event summary
- Olympus added three new urologists to its iTind Center of Excellence Program on September 10, 2026.
- The program requires annual re-certification and maintains high standards for training and patient outcomes.
- The iTind procedure is a minimally invasive treatment for benign prostatic hyperplasia (BPH).
- Two existing physicians were re-certified in the program.
The big picture
Olympus' expansion of its iTind Center of Excellence Program underscores the company's push to establish the procedure as a first-line treatment for BPH. With an aging male population and increasing demand for minimally invasive options, the program aims to create a network of highly trained physicians capable of delivering consistent outcomes. The strategic move positions Olympus to capture market share in a segment traditionally dominated by pharmaceutical and surgical interventions.
What we're watching
- Adoption Pace
- How quickly Olympus can expand the iTind Center of Excellence network to drive procedure adoption.
- Clinical Outcomes
- Whether the program's certification standards will translate into measurable improvements in patient outcomes.
- Competitive Positioning
- The extent to which Olympus can differentiate iTind in the growing market for minimally invasive BPH treatments.